Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Espin (ESPN) is a multifunctional, calcium-insensitive actin-bundling protein encoded by the *ESPN* gene in humans[1][3][5]. Espin is primarily associated with the actin-rich microvillus-type specializations such as stereocilia of sensory hair cells in the inner ear, where it is essential for organizing, elongating, and stabilizing parallel actin bundles[1][3][5]. It plays a crucial role in sensory transduction for hearing and balance, and mutations in ESPN disrupt stereocilia structure—causing autosomal recessive (DFNB36) and autosomal dominant non-syndromic sensorineural deafness in humans, and similar defects in mice (jerker phenotype)[1][3][5]. Espin activity depends on multiple interaction domains, including a unique WH2 domain facilitating targeted actin bundle assembly, and is regulated by binding partners like class III myosins[3]. There are no currently approved drugs targeting espin, and it is not considered a clinical therapeutic target. It functions as an essential cytoskeletal structural protein rather than a receptor, enzyme, or canonical drug target[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Espin (ESPN).